Sign in

CIK 0001472012

  • Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770694340
Phone
+1 610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake

Reading 56 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-23 Rosett Max Chief Financial Officer Grant or award +47,250 101,287
2026-07-23 Rosett Max Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +94,500 94,500
2026-06-15 Rosett Max Chief Financial Officer Option exercise 10b5-1 +60,000 $1.05 $63K 114,037
2026-06-15 Rosett Max Chief Financial Officer Sale 10b5-1 −60,000 $18.23 $1.1M 54,037
2026-06-15 Rosett Max Chief Financial Officer Option exercise · Stock Option (right to buy) 10b5-1 −60,000 0
2026-04-02 Rosett Max Chief Financial Officer Option exercise 10b5-1 +31,848 $1.05 $33K 79,324
2026-04-02 Rosett Max Chief Financial Officer Option exercise 10b5-1 +39,713 $1.35 $54K 119,037
2026-04-02 Rosett Max Chief Financial Officer Sale 10b5-1 −63,656 $21.91 $1.4M 55,381
2026-04-02 Rosett Max Chief Financial Officer Sale 10b5-1 −1,344 $22.48 $30K 54,037
2026-04-02 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) 10b5-1 −31,848 60,000
2026-04-02 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) 10b5-1 −39,713 0
2025-07-29 Rosett Max Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +207,000 207,000
2024-09-19 Rosett Max Chief Financial Officer Option exercise +42,000 $1.05 $44K 61,856
2024-09-19 Rosett Max Chief Financial Officer Sale −14,380 $16.01 $230K 47,476
2024-09-19 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) −42,000 91,848
2024-08-09 Rosett Max EVP, Operations & CFO Grant or award · Stock option (right to buy) +190,000 190,000
2024-05-16 Rosett Max EVP, Operations & CFO Grant or award · Stock option (right to buy) +30,000 30,000
2024-01-31 Rosett Max EVP, OPERATIONS & INTERIM CFO Grant or award · Stock option (right to buy) +175,000 175,000

Page 1 of 1 · 18 trades